Archive for November, 2009

Six-Month Neuroadaptation Period Found for Tecnis Multifocal IOL

Abbott Medical OpticsAbbott Medical Optics conducted a 250-eye study of the Tecnis multifocal intraocular lens (IOL) and measured results at three days, 30 days, 90 days, 150 days and 210 days after cataract surgery. Most of the study participants achieved their best vision after 180 days, which the researchers called a neuroadaptation period. During the last checkup, 96.8 percent of eyes could read at 20/20 (J2) without correction, with 83.2 percent reading at 20/15 (J1).

Baylor Vision Experts in Houston Join Trusted LASIK Surgeons Directory

Trusted LASIK SurgeonsTrusted LASIK Surgeons has announced that the LASIK Laser Cataract and vision correction experts at Baylor Vision of Houston have joined the Trusted LASIK Surgeons Directory, an informational resource for consumers seeking to improve their vision through laser eye surgery or other refractive surgery procedure and to find highly qualified refractive surgeon to perform their eye surgery. The Baylor Vision experts regularly treat patients seeking laser eye surgery, refractive procedures cataract surgery.

Laser eye surgery has no long-term effects on cornea

Mayo ClinicAccording to a study conducted at Mayo Clinic, Rochester, Minn., has found that laser eye surgery that corrects vision does not lead to later problems with the cornea – at least not after nine years . Two types of laser surgery—photorefractive keratectomy (PRK) and laser in situ keratomileusis (LASIK)—are often used to correct refractive errors such as nearsightedness.

LenSar develops new laser therapy

LensAR, Inc.LenSar  has developed new laser therapy that can potentially remove cataract from people’s eyes more efficiently. The technology is being tested in clinical trials. It is commonly believed that cataract surgeries, which totaled at more than three million procedures in the U.S. last year, are already being done with a laser device. Few years ago, the company began to safely but partially treat human eyes with the laser in trials outside the U.S.